| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09774f7cc49b24784545f5c13028212d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddcf2c315c108125b002b152dccca9cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d3a67bb4cc79150cf2eeb636c2abb1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_618a9601c96effc764fa6988ee116ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4964c50ba462a00a1c79bc6a82234b |
| publicationDate |
2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NL-2017670-B1 |
| titleOfInvention |
Molecular indicators for predicting response to hormonal therapy in breast cancer |
| abstract |
The invention provides for a method for predicting responsiveness, i.e. sensitivity or resistance, of an estrogen receptor α-positive tumor to hormonal therapy based upon predictive biomarkers. The invention will aid in determining a suitable therapy for ERα-positive cancer patients. Kits and arrays for predicting responsiveness of an ERα-positive tumor to hormonal therapy are also provided. Finally, the invention provides for use of hormonal therapy or chemotherapy in a select patient group, i.e., those identified based on predicted response to hormonal therapy. |
| priorityDate |
2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |